NCT05657847 Novel Complex Radiodiagnostics of Peripherial Arthropathies
| NCT ID | NCT05657847 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Semmelweis University |
| Condition | Arthritis, Rheumatoid |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-03-07 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-03-07 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic peripherial arthritides are common diseases with soaring public health consequences. Our goal is to assess the role of photon-counting detector computed tomography in the diagnostics of peripherial arthropathies.
Eligibility Criteria
Inclusion Criteria: * Rheumatoid arthritis (EULAR/ACR Criteria) / Psoriatic arthritis (CASPAR Criteria)/ Crystal arthropathies * signed informed consent Exclusion Criteria: * age: \<18 years, \> 100 years * pregnant * breastfeeding
Frequently Asked Questions
Who can join the NCT05657847 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Arthritis, Rheumatoid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05657847 currently recruiting?
Yes, NCT05657847 is actively recruiting participants. Visit ClinicalTrials.gov or contact Semmelweis University to inquire about joining.
Where is the NCT05657847 trial being conducted?
This trial is being conducted at Budapest, Hungary, Budapest, Hungary, Budapest, Hungary.
Who is sponsoring the NCT05657847 clinical trial?
NCT05657847 is sponsored by Semmelweis University. The trial plans to enroll 500 participants.